Evidence map›Paper›PMID 36357587›Full record

ArticleCommunications medicine2022

Spatial modeling of vaccine deserts as barriers to controlling SARS-CoV-2.

Benjamin Rader, Christina M Astley, Kara Sewalk, Paul L Delamater, Kathryn Cordiano, Laura Wronski, Jessica Malaty Rivera, Kai Hallberg, Megan F Pera, Jonathan Cantor and 5 more

Abstract read
In one paragraph

Article in Communications medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Disparities in suicide risk trajectories among youth during the COVID-19 pandemic.Journal of research on adolescence : the official journal of the Society for Research on Adolescence · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Benjamin RaderComputational Epidemiology Lab, Boston Children's Hospital, Boston, MA, USA. benjamin.rader@childrens.harvard.edu.
Christina M AstleyComputational Epidemiology Lab, Boston Children's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5063-8470
Kara SewalkComputational Epidemiology Lab, Boston Children's Hospital, Boston, MA, USA.
Paul L DelamaterDepartment of Geography and Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0003-3627-9739
Kathryn CordianoComputational Epidemiology Lab, Boston Children's Hospital, Boston, MA, USA.
Laura WronskiSurveyMonkey, San Mateo, CA, USA.
Jessica Malaty RiveraThe COVID Tracking Project at the Atlantic, District of Columbia, USA.ORCID http://orcid.org/0000-0002-6339-8584
Kai HallbergCastlight Health, San Francisco, CA, USA.
Megan F PeraCastlight Health, San Francisco, CA, USA.
Jonathan CantorRAND Corporation, Santa Monica, CA, USA.
Christopher M WhaleyRAND Corporation, Santa Monica, CA, USA.
Dena M BravataCastlight Health, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-4513-8279
Leslie LeeNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-0333-8838
Anita Patel *National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
John S Brownstein *Computational Epidemiology Lab, Boston Children's Hospital, Boston, MA, USA. john.brownstein@childrens.harvard.edu.ORCID http://orcid.org/0000-0001-8568-5317

Funding

Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Seasonal and Viral Determinants of Type 1 Diabetes Onset, Remission, and Glycemic ControlK23DK120899 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI ASTLEY, CHRISTINA M. · 2019 to 2021
$682k
Facebook (FB) INB1116217Google TF2003-089662NICHD NIH HHS P2C HD050924NIDDK NIH HHS K23 DK120899
6 · The paper itself

Abstract

backgroundCOVID-19 vaccine distribution is at risk of further propagating the inequities of COVID-19, which in the United States (US) has disproportionately impacted the elderly, people of color, and the medically vulnerable. We sought to measure if the disparities seen in the geographic distribution of other COVID-19 healthcare resources were also present during the initial rollout of the COVID-19 vaccine.

methodsUsing a comprehensive COVID-19 vaccine database (VaccineFinder), we built an empirically parameterized spatial model of access to essential resources that incorporated vaccine supply, time-willing-to-travel for vaccination, and previous vaccination across the US. We then identified vaccine deserts-US Census tracts with localized, geographic barriers to vaccine-associated herd immunity. We link our model results with Census data and two high-resolution surveys to understand the distribution and determinates of spatially accessibility to the COVID-19 vaccine.

resultsWe find that in early 2021, vaccine deserts were home to over 30 million people, >10% of the US population. Vaccine deserts were concentrated in rural locations and communities with a higher percentage of medically vulnerable populations. We also find that in locations of similar urbanicity, early vaccination distribution disadvantaged neighborhoods with more people of color and older aged residents.

conclusionGiven sufficient vaccine supply, data-driven vaccine distribution to vaccine deserts may improve immunization rates and help control COVID-19.

Identifiers

PMID36357587
PMCPMC9649755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.